Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.
Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.
Aveanna Healthcare Holdings insider entities reported sizable stock sales. On June 30, 2026, investment entities associated with Robert M. Williams Jr., including J.H. Whitney VII, L.P. and related Iliad holding vehicles, sold a combined 3,000,000 shares of Aveanna common stock at $8.01 per share in open-market transactions.
After these sales, the entities continued to hold large indirect positions, such as 10,112,123 shares held by J.H. Whitney VII, L.P., 1,813,795 shares held by JHW Iliad Holdings LLC, and 190,130 shares held by JHW Iliad Holdings II LLC, with additional shares held by PSA-affiliated holding companies. Footnotes state that Williams and the managing entities may be deemed to share voting and dispositive power, but each disclaims beneficial ownership except to the extent of any pecuniary interest.
Aveanna Healthcare Holdings insider-related entities sold common stock in a sizable secondary transaction. Investment entities associated with Paul R. Vigano sold an aggregate 3,000,000 shares of Aveanna Healthcare common stock on June 30, 2026 at an average price of $8.01 per share in open-market or private transactions.
After these sales, JHW Iliad Holdings II LLC held 190,130 shares, JHW Iliad Holdings LLC held 1,813,795 shares, and J.H. Whitney VII, L.P. held 10,112,123 shares, all reported as indirect holdings. Additional indirect positions were 1,426,034 shares held by PSA Iliad Holdings LLC and 15,523,810 shares held by PSA Healthcare Investment Holdings LLC, while Vigano reported no direct holdings. Footnotes state that various J.H. Whitney-affiliated entities and Vigano may be deemed to share voting and dispositive power and each disclaims beneficial ownership except to the extent of pecuniary interest.
Aveanna Healthcare Holdings’ major shareholder group reported an open-market sale of common stock. An entity associated with J.H. Whitney Equity Partners VII, LLC sold 2,419,035 shares of Aveanna common stock at $8.01 per share on June 30, 2026.
After this transaction, that entity held 10,112,123 shares indirectly, while related entities held 1,426,034 and 15,523,810 shares indirectly. The reporting person and its affiliates may be deemed to share voting and dispositive power over these holdings but disclaim beneficial ownership beyond their pecuniary interest.
JHW ILIAD HOLDINGS II LLC submitted notices under Form 144 reporting proposed and recent resale transactions in Aveanna Healthcare Holdings, Inc. common stock. The excerpt lists a 06/24/2026 entry for 7,648 shares and a 06/03/2026 entry for 109,847 shares, with corresponding dollar amounts shown.
Aveanna Healthcare Holdings Inc. resale notice: a selling holder, JHW Iliad Holdings LLC (represented by RBC Capital Markets LLC), filed Form 144 notifying proposed sales of common stock in connection with prior private placement activity. The excerpt lists two reported sale entries with 72,963 and 1,047,913 shares and associated dollar amounts.
The filings reference a private placement dated 03/24/2020 and include transaction dates 06/03/2026 and 06/24/2026. The notice is a regulatory disclosure of planned dispositions; timing and distribution mechanics are not specified in the provided excerpt.
Aveanna Healthcare Holdings Inc. submitted a Form 144 registering 2,419,035 shares of common stock for sale. The filing lists recent proposed/reported transactions by J.H. Whitney VII, LP, including 919,389 shares on 06/24/2026 and 5,842,240 shares on 06/03/2026.
Aveanna Healthcare Holdings, Inc. insider filing shows entities associated with Robert M. Williams Jr. reported open‑market sales of a combined 1,000,000 shares of common stock at $8.00 per share on June 24, 2026. The sales were made by JHW Iliad Holdings II LLC, JHW Iliad Holdings LLC and J.H. Whitney VII, L.P., all reported as indirect holdings.
After these transactions, the filing shows 245,251 shares held by JHW Iliad Holdings II LLC, 2,339,639 shares held by JHW Iliad Holdings LLC and 12,531,158 shares held by J.H. Whitney VII, L.P., with additional indirect holdings at PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC. Footnotes state that Williams, through various management roles, may be deemed to share voting and dispositive power over these entities’ shares but disclaims beneficial ownership except for his pecuniary interest.
Aveanna Healthcare Holdings' major shareholder J.H. Whitney VII, L.P., an entity associated with J.H. Whitney Equity Partners VII, LLC, reported an open-market sale of 919,389 shares of common stock at $8.00 per share on June 24, 2026. After this sale, J.H. Whitney VII, L.P. held 12,531,158 Aveanna shares indirectly. Related entities PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC were shown with 1,426,034 and 15,523,810 indirectly held shares, respectively, while direct holdings for the reporting person were listed as zero. The reporting entities may be deemed to share voting and dispositive power over these positions but disclaim beneficial ownership except to the extent of their pecuniary interest.
Aveanna Healthcare Holdings insider filing shows entities linked to Paul R. Vigano selling Aveanna common stock. On June 24, 2026, stockholder entities associated with J.H. Whitney funds sold a combined 1,000,000 shares of common stock at $8.00 per share in open‑market transactions.
The sales included 7,648 shares held by JHW Iliad Holdings II LLC, 72,963 shares held by JHW Iliad Holdings LLC, and 919,389 shares held by J.H. Whitney VII, L.P. After these trades, those entities held 245,251, 2,339,639 and 12,531,158 shares, respectively. Other related entities, PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC, reported indirect holdings as of the same date.
Footnotes state that various J.H. Whitney management entities may be deemed to share voting and dispositive power over these shares, and that Paul R. Vigano, through roles at these entities, may be deemed to share such power but disclaims beneficial ownership except for his pecuniary interest.
Avanna Healthcare Holdings submitted a Section 144 notice reporting a proposed or recent resale of 109,847 shares of Common Stock. The filing shows a trade dated 06/03/2026 with proceeds of $685,445 and the notice dated 06/24/2026. The shares trace to a private placement dated 03/24/2020.